Literature DB >> 18511946

Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA.

Lars G Fritsche1, Thomas Loenhardt, Andreas Janssen, Sheila A Fisher, Andrea Rivera, Claudia N Keilhauer, Bernhard H F Weber.   

Abstract

Age-related macular degeneration (AMD) is a prevalent multifactorial disorder of the central retina. Genetic variants at two chromosomal loci, 1q31 and 10q26, confer major disease risks, together accounting for more than 50% of AMD pathology. Signals at 10q26 center over two nearby genes, ARMS2 (age-related maculopathy susceptibility 2, also known as LOC387715) and HTRA1 (high-temperature requirement factor A1), suggesting two equally probable candidates. Here we show that a deletion-insertion polymorphism in ARMS2 (NM_001099667.1:c.(*)372_815del443ins54) is strongly associated with AMD, directly affecting the transcript by removing the polyadenylation signal and inserting a 54-bp element known to mediate rapid mRNA turnover. As a consequence, expression of ARMS2 in homozygous carriers of the indel variant is not detectable. Confirming previous findings, we demonstrate a mitochondrial association of the normal protein and further define its retinal localization to the ellipsoid region of the photoreceptors. Our data suggest that ARMS2 has a key role in AMD, possibly through mitochondria-related pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511946     DOI: 10.1038/ng.170

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  152 in total

1.  Copy number variations in candidate genes in neovascular age-related macular degeneration.

Authors:  Melissa M Liu; Elvira Agrón; Emily Chew; Catherine Meyerle; Frederick L Ferris; Chi-Chao Chan; Jingsheng Tuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-16       Impact factor: 4.799

Review 2.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

Review 3.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 4.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  Choroidal neovascular membrane adjacent to an old macular hole sparing the center of the hole.

Authors:  Yoriko Nakanishi; Yasushi Tamura; Tomoko Nagai; Hiroyuki Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

Review 6.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

Review 7.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

8.  The effect of long-term systemic immunosuppressive drug use on druse formation: a new perspective to age-related macular degeneration

Authors:  Özkan Sever; Ridvan Mercan
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

9.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

10.  Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Authors:  Jeannette J Yu; Elvira Agrón; Traci E Clemons; Amitha Domalpally; Freekje van Asten; Tiarnan D Keenan; Catherine Cukras; Emily Y Chew
Journal:  Ophthalmology       Date:  2018-08-22       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.